{"id":1091,"date":"2018-02-10T19:25:00","date_gmt":"2018-02-10T19:25:00","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1091"},"modified":"2026-02-24T16:00:57","modified_gmt":"2026-02-24T16:00:57","slug":"risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/","title":{"rendered":"Risk category system to identify pituitary adenoma patients with AIP mutations (Contributed by Dr. Francisca Caimari)"},"content":{"rendered":"<p>Pituitary tumours arise from the master gland located at the bottom of the brain. They can cause severe disease due to their abnormal hormone secretion and local damaging key structures such as vision. Around 5% of pituitary adenomas occur due to a heritable condition, we specifically studied patients and their families with mutation in the AIP gene often leading to abnormally rapid growth and gigantism.<\/p>\n<p>With the help of a large international cohort of patients, we tried to predict, based on simple clinical data such as age of onset of disease and tumour size, who may carry an AIP gene mutation. This will help to identify patients who should be screened for the mutation and whose family therefore may benefit from early diagnosis and treatment. (<a href=\"http:\/\/jmg.bmj.com\/content\/early\/2018\/02\/10\/jmedgenet-2017-104957\">http:\/\/jmg.bmj.com\/content\/early\/2018\/02\/10\/jmedgenet-2017-104957<\/a> )<\/p>\n<p><a href=\"https:\/\/blogs.bmj.com\/jmg\/files\/2018\/02\/Fig-2-blog-.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1092\" src=\"https:\/\/blogs.bmj.com\/jmg\/files\/2018\/02\/Fig-2-blog--192x300.jpg\" alt=\"\" width=\"192\" height=\"300\" \/><\/a><!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pituitary tumours arise from the master gland located at the bottom of the brain. They can cause severe disease due to their abnormal hormone secretion and local damaging key structures such as vision. Around 5% of pituitary adenomas occur due to a heritable condition, we specifically studied patients and their families with mutation in the [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1091","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Risk category system to identify pituitary adenoma patients with AIP mutations (Contributed by Dr. Francisca Caimari) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Risk category system to identify pituitary adenoma patients with AIP mutations (Contributed by Dr. Francisca Caimari) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Pituitary tumours arise from the master gland located at the bottom of the brain. They can cause severe disease due to their abnormal hormone secretion and local damaging key structures such as vision. Around 5% of pituitary adenomas occur due to a heritable condition, we specifically studied patients and their families with mutation in the [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2018-02-10T19:25:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T16:00:57+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Risk category system to identify pituitary adenoma patients with AIP mutations (Contributed by Dr. Francisca Caimari)\",\"datePublished\":\"2018-02-10T19:25:00+00:00\",\"dateModified\":\"2026-02-24T16:00:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/\"},\"wordCount\":148,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2018\\\/02\\\/Fig-2-blog--192x300.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/\",\"name\":\"Risk category system to identify pituitary adenoma patients with AIP mutations (Contributed by Dr. Francisca Caimari) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2018\\\/02\\\/Fig-2-blog--192x300.jpg\",\"datePublished\":\"2018-02-10T19:25:00+00:00\",\"dateModified\":\"2026-02-24T16:00:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/02\\\/10\\\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Risk category system to identify pituitary adenoma patients with AIP mutations (Contributed by Dr. Francisca Caimari)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Risk category system to identify pituitary adenoma patients with AIP mutations (Contributed by Dr. Francisca Caimari) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/","og_locale":"en_US","og_type":"article","og_title":"Risk category system to identify pituitary adenoma patients with AIP mutations (Contributed by Dr. Francisca Caimari) - JMG Contact blog","og_description":"Pituitary tumours arise from the master gland located at the bottom of the brain. They can cause severe disease due to their abnormal hormone secretion and local damaging key structures such as vision. Around 5% of pituitary adenomas occur due to a heritable condition, we specifically studied patients and their families with mutation in the [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/","og_site_name":"JMG Contact blog","article_published_time":"2018-02-10T19:25:00+00:00","article_modified_time":"2026-02-24T16:00:57+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Risk category system to identify pituitary adenoma patients with AIP mutations (Contributed by Dr. Francisca Caimari)","datePublished":"2018-02-10T19:25:00+00:00","dateModified":"2026-02-24T16:00:57+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/"},"wordCount":148,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2018\/02\/Fig-2-blog--192x300.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/","url":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/","name":"Risk category system to identify pituitary adenoma patients with AIP mutations (Contributed by Dr. Francisca Caimari) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2018\/02\/Fig-2-blog--192x300.jpg","datePublished":"2018-02-10T19:25:00+00:00","dateModified":"2026-02-24T16:00:57+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/02\/10\/risk-category-system-to-identify-pituitary-adenoma-patients-with-aip-mutations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Risk category system to identify pituitary adenoma patients with AIP mutations (Contributed by Dr. Francisca Caimari)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1091"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1091\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1091"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1091"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}